Radiopharm Theranostics Limited
RADX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | – | $19 | – |
| Short-Term Investments | $0 | – | $0 | – |
| Receivables | $6 | – | $1 | – |
| Inventory | $0 | – | $0 | – |
| Other Curr. Assets | $2 | – | $3 | – |
| Total Curr. Assets | $44 | – | $23 | – |
| Property Plant & Equip (Net) | $0 | – | $0 | – |
| Goodwill | $0 | – | $0 | – |
| Intangibles | $6 | – | $49 | – |
| Long-Term Investments | $0 | – | $0 | – |
| Tax Assets | $0 | – | $0 | – |
| Other NC Assets | $0 | – | $0 | – |
| Total NC Assets | $48 | – | $49 | – |
| Other Assets | $0 | – | $0 | – |
| Total Assets | $92 | – | $72 | – |
| Liabilities | – | – | – | – |
| Payables | $3 | – | $6 | – |
| Short-Term Debt | $0 | – | $0 | – |
| Tax Payable | $0 | – | $0 | – |
| Deferred Revenue | $3 | – | $0 | – |
| Other Curr. Liab. | $7 | – | $11 | – |
| Total Curr. Liab. | $13 | – | $18 | – |
| LT Debt | $0 | – | $0 | – |
| Deferred Rev, NC | $0 | – | $0 | – |
| Deferred Tax Liab, NC | $0 | – | $0 | – |
| Other NC Liab. | $27 | – | $27 | – |
| Total NC Liab. | $27 | – | $27 | – |
| Other Liabilities | $0 | – | $0 | – |
| Cap. Leases | $0 | – | $0 | – |
| Total Liabilities | $40 | – | $45 | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | – | $0 | – |
| Common Stock | $168 | – | $101 | – |
| Retained Earnings | -$128 | – | -$111 | – |
| AOCI | $12 | – | $38 | – |
| Other Equity | $1 | – | $1 | – |
| Total Equity | $53 | – | $28 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | – | -$1 | – |
| Total Liab. & Tot. Equity | $92 | – | $72 | – |
| Net Debt | -$36 | $0 | -$19 | $0 |